Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Nature Structural & Molecular Biology
|
January 5, 2007
Insights into DNA deaminases
Silvestro G Conticello, Marc-Andre Langlois, Michael S Neuberger
Advances in Immunology
|
June 15, 2007
DNA deamination in immunity: AID in the context of its APOBEC relatives
Silvestro G Conticello, Marc-Andre Langlois, Zizhen Yang, et al.
The Journal of Allergy and Clinical Immunology
|
December 30, 2023
Booster doses of COVID-19 vaccine enhance neutralization efficiency against XBB.1.5
Elsa Sakr, Nisha D Almeida, Marc-Andre Langlois, et al.
Nucleic Acids Research
|
July 20, 2005
HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence
Dong-Ho Kim, Marc-Andre Langlois, Kwang-Back Lee, et al.
BMJ Open
|
October 31, 2023
Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination
Alexa Keeshan, Yannick Galipeau, Aliisa Heiskanen, et al.
Frontiers in Immunology
|
March 4, 2024
The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study
Nisha D Almeida, Ian Schiller, Danbing Ke, et al.
Vaccine
|
June 29, 2024
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies
Sita Bhella, Allison M Wilkin, Katrina Hueniken, et al.
British Journal of Haematology
|
October 10, 2025
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies
Abi Vijenthira, Sita Bhella, Katrina Hueniken, et al.
Frontiers in Immunology
|
February 5, 2025
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections
Dana Unninayar, Emilia L Falcone, Hugo Chapdelaine, et al.
Transplantation and Cellular Therapy
|
November 10, 2025
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy
C Arianne Buchan, Gerard Agbayani, Katrina Hueniken, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Nature Structural & Molecular Biology
|
January 5, 2007
Insights into DNA deaminases
Silvestro G Conticello, Marc-Andre Langlois, Michael S Neuberger
Advances in Immunology
|
June 15, 2007
DNA deamination in immunity: AID in the context of its APOBEC relatives
Silvestro G Conticello, Marc-Andre Langlois, Zizhen Yang, et al.
The Journal of Allergy and Clinical Immunology
|
December 30, 2023
Booster doses of COVID-19 vaccine enhance neutralization efficiency against XBB.1.5
Elsa Sakr, Nisha D Almeida, Marc-Andre Langlois, et al.
Nucleic Acids Research
|
July 20, 2005
HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence
Dong-Ho Kim, Marc-Andre Langlois, Kwang-Back Lee, et al.
BMJ Open
|
October 31, 2023
Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination
Alexa Keeshan, Yannick Galipeau, Aliisa Heiskanen, et al.
Frontiers in Immunology
|
March 4, 2024
The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study
Nisha D Almeida, Ian Schiller, Danbing Ke, et al.
Vaccine
|
June 29, 2024
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies
Sita Bhella, Allison M Wilkin, Katrina Hueniken, et al.
British Journal of Haematology
|
October 10, 2025
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies
Abi Vijenthira, Sita Bhella, Katrina Hueniken, et al.
Frontiers in Immunology
|
February 5, 2025
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections
Dana Unninayar, Emilia L Falcone, Hugo Chapdelaine, et al.
Transplantation and Cellular Therapy
|
November 10, 2025
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy
C Arianne Buchan, Gerard Agbayani, Katrina Hueniken, et al.
Page
of 2